HK1136576A1 - Azapeptide derivatives as hiv protease inhibitors - Google Patents
Azapeptide derivatives as hiv protease inhibitorsInfo
- Publication number
- HK1136576A1 HK1136576A1 HK10104316.7A HK10104316A HK1136576A1 HK 1136576 A1 HK1136576 A1 HK 1136576A1 HK 10104316 A HK10104316 A HK 10104316A HK 1136576 A1 HK1136576 A1 HK 1136576A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protease inhibitors
- hiv protease
- azapeptide derivatives
- azapeptide
- derivatives
- Prior art date
Links
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93420107P | 2007-06-12 | 2007-06-12 | |
US6762708P | 2008-02-29 | 2008-02-29 | |
HK09105433.5A HK1127345A1 (en) | 2007-06-12 | 2009-06-17 | Azapeptide derivatives as hiv protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1136576A1 true HK1136576A1 (en) | 2010-07-02 |
Family
ID=39730784
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09105433.5A HK1127345A1 (en) | 2007-06-12 | 2009-06-17 | Azapeptide derivatives as hiv protease inhibitors |
HK10104316.7A HK1136576A1 (en) | 2007-06-12 | 2009-06-17 | Azapeptide derivatives as hiv protease inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09105433.5A HK1127345A1 (en) | 2007-06-12 | 2009-06-17 | Azapeptide derivatives as hiv protease inhibitors |
Country Status (26)
Country | Link |
---|---|
US (4) | US20090036357A1 (xx) |
EP (3) | EP2116532B1 (xx) |
JP (1) | JP2010529196A (xx) |
KR (2) | KR20120029480A (xx) |
CN (2) | CN101711237B (xx) |
AR (1) | AR066972A1 (xx) |
AT (2) | ATE447554T1 (xx) |
AU (1) | AU2008267048C1 (xx) |
BR (2) | BRPI0813911A2 (xx) |
CA (1) | CA2692028C (xx) |
CO (1) | CO6241121A2 (xx) |
CY (1) | CY1109766T1 (xx) |
DE (1) | DE602008000255D1 (xx) |
DK (1) | DK2003120T3 (xx) |
ES (3) | ES2356334T3 (xx) |
HK (2) | HK1127345A1 (xx) |
HR (1) | HRP20100065T1 (xx) |
MX (1) | MX2009013565A (xx) |
PL (1) | PL2003120T3 (xx) |
PT (1) | PT2003120E (xx) |
RS (1) | RS51226B (xx) |
RU (2) | RU2448958C2 (xx) |
SI (1) | SI2003120T1 (xx) |
TW (1) | TW200908970A (xx) |
WO (1) | WO2008156632A1 (xx) |
ZA (1) | ZA200909079B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200835693A (en) * | 2007-02-23 | 2008-09-01 | Auspex Pharmaceuticals Inc | Preparation and utility of non-nucleoside reverse transcriptase inhibitors |
JP2010529196A (ja) | 2007-06-12 | 2010-08-26 | コンサート ファーマシューティカルズ インコーポレイテッド | アザペプチド誘導体 |
EP2334318B1 (en) * | 2008-10-06 | 2016-02-10 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | Hiv-1 integrase derived stimulatory peptides interfering with integrase - rev protein binding |
WO2010132663A1 (en) * | 2009-05-13 | 2010-11-18 | Concert Pharmaceticals, Inc. | Pegylated azapeptide derivatives as hiv protease inhibitors |
WO2010135424A1 (en) * | 2009-05-19 | 2010-11-25 | Glaxosmithkline Llc | Chemical compounds |
NZ600156A (en) * | 2009-12-21 | 2015-01-30 | Janssen R & D Ireland | Degradable removable implant for the sustained release of an active compound |
WO2011080562A1 (en) | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
JP5668177B2 (ja) | 2011-06-20 | 2015-02-12 | ハー・ルンドベック・アクチエゼルスカベット | 統合失調症の治療のための重水素化1−ピペラジノ−3−フェニルインダン |
CN106543073A (zh) * | 2015-09-17 | 2017-03-29 | 宁波杰尔盛化工有限公司 | 2-[4-(2-吡啶基)苄基]-肼羧酸叔丁酯的制备方法 |
HRP20211687T1 (hr) * | 2015-12-02 | 2022-03-04 | Merck Sharp & Dohme Corp. | Farmaceutske kompozicije koje sadrže doravirin, tenofovir dizoproksil fumarat i lamivudin |
JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
WO2019025250A1 (en) | 2017-08-04 | 2019-02-07 | Basf Se | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI |
CN113164398B (zh) | 2018-06-29 | 2023-11-03 | 因赛特公司 | Axl/mer抑制剂的制剂 |
TWI829205B (zh) | 2018-07-30 | 2024-01-11 | 美商基利科學股份有限公司 | 抗hiv化合物 |
AU2021257341A1 (en) * | 2020-04-16 | 2022-11-17 | The Medical College Of Wisconsin, Inc. | Aerosolized formulations of HIV protease inhibitors for the treatment of airway reflux |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206497B1 (en) | 1985-05-15 | 1994-07-20 | The Wellcome Foundation Limited | Therapeutic nucleosides and their preparation |
GB8815265D0 (en) | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
US5552558A (en) | 1989-05-23 | 1996-09-03 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
ATE417836T1 (de) | 1992-12-29 | 2009-01-15 | Abbott Lab | Verfahren und intermediate zur herstellung von retroviralen proteasehemmern |
US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US6221335B1 (en) | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
KR100477070B1 (ko) | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US5849911A (en) | 1996-04-22 | 1998-12-15 | Novartis Finance Corporation | Antivirally active heterocyclic azahexane derivatives |
TW409125B (en) * | 1996-04-22 | 2000-10-21 | Novartis Ag | Antivirally active heterocyclic azahexane derivatives |
WO1997046514A1 (en) | 1996-05-31 | 1997-12-11 | Novartis Ag | Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues |
US6087383A (en) * | 1998-01-20 | 2000-07-11 | Bristol-Myers Squibb Company | Bisulfate salt of HIV protease inhibitor |
US6440710B1 (en) | 1998-12-10 | 2002-08-27 | The Scripps Research Institute | Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds |
GB9914821D0 (en) | 1999-06-24 | 1999-08-25 | Glaxo Group Ltd | Compounds |
GB9925962D0 (en) | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
ATE234299T1 (de) | 1999-12-03 | 2003-03-15 | Pfizer Prod Inc | Sulfamoylheteroarylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel |
NZ528689A (en) | 2001-05-03 | 2005-03-24 | F | Pharmaceutical dosage form of amorphous nelfinavir mesylate |
EP1392262A1 (en) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
RU2316341C2 (ru) | 2001-08-31 | 2008-02-10 | Бристол-Маерс Сквибб Компани | Применение атазанавира в терапии вич-инфекции |
TW200413273A (en) | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
WO2005027855A2 (en) | 2003-02-21 | 2005-03-31 | Jarrow Formulas, Inc. | Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors |
US20050131017A1 (en) | 2003-12-11 | 2005-06-16 | Degoey David A. | HIV protease inhibiting compounds |
US20050148523A1 (en) | 2003-12-15 | 2005-07-07 | Colonno Richard J. | Method of treating HIV infection in atazanavir-resistant patients using a combination of atazanavir and another protease inhibitor |
US7829720B2 (en) * | 2004-05-04 | 2010-11-09 | Bristol-Myers Squibb Company | Process for preparing atazanavir bisulfate and novel forms |
US7718633B2 (en) * | 2004-07-06 | 2010-05-18 | Abbott Laboratories | Prodrugs of HIV protease inhibitors |
AU2005292339A1 (en) | 2004-09-29 | 2006-04-13 | Cordis Corporation | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
RU2403066C2 (ru) | 2004-12-03 | 2010-11-10 | Мерк Шарп Энд Домэ Корп | Применение атазанавира для улучшения фармакокинетики лекарственных средств, метаболизируемых ugt1a1 |
AU2006299424A1 (en) | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
US7750168B2 (en) | 2006-02-10 | 2010-07-06 | Sigma-Aldrich Co. | Stabilized deuteroborane-tetrahydrofuran complex |
JO2630B1 (en) | 2006-04-13 | 2012-06-17 | نوفارتيس ايه جي | Organic compounds |
WO2008030382A1 (en) | 2006-09-05 | 2008-03-13 | Schering Corporation | Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis |
JP2010529196A (ja) | 2007-06-12 | 2010-08-26 | コンサート ファーマシューティカルズ インコーポレイテッド | アザペプチド誘導体 |
US20090076097A1 (en) | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched atazanavir |
WO2010132663A1 (en) | 2009-05-13 | 2010-11-18 | Concert Pharmaceticals, Inc. | Pegylated azapeptide derivatives as hiv protease inhibitors |
-
2008
- 2008-06-12 JP JP2010512186A patent/JP2010529196A/ja active Pending
- 2008-06-12 EP EP09075359A patent/EP2116532B1/en active Active
- 2008-06-12 AR ARP080102501A patent/AR066972A1/es unknown
- 2008-06-12 DE DE602008000255T patent/DE602008000255D1/de active Active
- 2008-06-12 AT AT08252023T patent/ATE447554T1/de active
- 2008-06-12 MX MX2009013565A patent/MX2009013565A/es active IP Right Grant
- 2008-06-12 RS RSP-2010/0034A patent/RS51226B/sr unknown
- 2008-06-12 AU AU2008267048A patent/AU2008267048C1/en not_active Ceased
- 2008-06-12 ES ES08252023T patent/ES2356334T3/es active Active
- 2008-06-12 EP EP11155667A patent/EP2322509B1/en active Active
- 2008-06-12 TW TW097122018A patent/TW200908970A/zh unknown
- 2008-06-12 PT PT08252023T patent/PT2003120E/pt unknown
- 2008-06-12 ES ES11155667T patent/ES2394952T3/es active Active
- 2008-06-12 AT AT09075359T patent/ATE536343T1/de active
- 2008-06-12 PL PL08252023T patent/PL2003120T3/pl unknown
- 2008-06-12 BR BRPI0813911-3A patent/BRPI0813911A2/pt not_active IP Right Cessation
- 2008-06-12 RU RU2010100821/04A patent/RU2448958C2/ru not_active IP Right Cessation
- 2008-06-12 CN CN2008800216013A patent/CN101711237B/zh not_active Expired - Fee Related
- 2008-06-12 CN CN2011102869075A patent/CN102424668A/zh active Pending
- 2008-06-12 DK DK08252023.0T patent/DK2003120T3/da active
- 2008-06-12 KR KR1020127003399A patent/KR20120029480A/ko not_active Application Discontinuation
- 2008-06-12 SI SI200830012T patent/SI2003120T1/sl unknown
- 2008-06-12 CA CA2692028A patent/CA2692028C/en not_active Expired - Fee Related
- 2008-06-12 US US12/157,712 patent/US20090036357A1/en not_active Abandoned
- 2008-06-12 BR BRPI0823520-1A patent/BRPI0823520A2/pt not_active IP Right Cessation
- 2008-06-12 KR KR1020107000675A patent/KR101185899B1/ko not_active IP Right Cessation
- 2008-06-12 EP EP08252023A patent/EP2003120B9/en active Active
- 2008-06-12 ES ES09075359T patent/ES2395137T3/es active Active
- 2008-06-12 WO PCT/US2008/007331 patent/WO2008156632A1/en active Application Filing
-
2009
- 2009-06-17 HK HK09105433.5A patent/HK1127345A1/xx not_active IP Right Cessation
- 2009-06-17 HK HK10104316.7A patent/HK1136576A1/xx not_active IP Right Cessation
- 2009-12-11 CO CO09141805A patent/CO6241121A2/es not_active Application Discontinuation
- 2009-12-18 ZA ZA2009/09079A patent/ZA200909079B/en unknown
-
2010
- 2010-02-03 HR HR20100065T patent/HRP20100065T1/hr unknown
- 2010-02-03 CY CY20101100099T patent/CY1109766T1/el unknown
- 2010-04-06 US US12/755,184 patent/US8158805B2/en not_active Expired - Fee Related
-
2012
- 2012-01-19 RU RU2012101881/04A patent/RU2012101881A/ru not_active Application Discontinuation
- 2012-03-02 US US13/411,089 patent/US8258309B2/en active Active
- 2012-08-27 US US13/595,511 patent/US20130041156A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1136576A1 (en) | Azapeptide derivatives as hiv protease inhibitors | |
IL197777A0 (en) | Enantiomerically pure phosphoindoles as hiv inhibitors | |
EP2139883A4 (en) | INHIBITORS OF HIV-1 PROTEASE | |
SI2078001T1 (sl) | Derivati diazepan-acetamida kot selektivni zaviralci 11 -hsd1 | |
HK1127351A1 (zh) | 抗病毒蛋白酶抑制劑 | |
IL196000A0 (en) | 2-arylindole derivatives as npges-i inhibitors | |
EP2304043A4 (en) | HIV PROTEASE INHIBITORS AND METHOD FOR THEIR USE | |
EP2632895A4 (en) | HIV PROTEASE INHIBITORS | |
EP2435037A4 (en) | HIV PROTEASE INHIBITORS | |
IL183850A0 (en) | Hiv protease inhibitors | |
AU2007337830A8 (en) | Benzenesulfonamide derivatives as HIV protease inhibitors | |
EP1855672A4 (en) | HIV PROTEASE INHIBITORS | |
EP2244571A4 (en) | SMALL INHIBITORY MOLECULES OF HIV PROTEASES | |
ZA200804607B (en) | Substituted aminophenylsulfonamide compounds as HIV protease inhibitor | |
EP2313426A4 (en) | NOVEL PROTEASE INHIBITORS | |
EP2134336A4 (en) | HIV PROTEASE INHIBITORS DERIVED FROM BENZOFURAN | |
ZA201102179B (en) | Protease inhibitors | |
ZA200706305B (en) | HIV protease inhibitors | |
GB0817425D0 (en) | Protease inhibitors | |
ZA200902172B (en) | Enantiomerically pure phosphoindoles as HIV inhibitors | |
ZA200804610B (en) | Aminophenylsulfonamide derivatives as HIV protease inhibitor | |
GB0700369D0 (en) | Protease inhibitors | |
GB0705212D0 (en) | Protease inhibitors | |
GB0712544D0 (en) | Protease inhibitors | |
GB0700378D0 (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160612 |